Funding for this research was provided by:
National Cancer Institute (K24CA172355)
Lineberger Comprehensive Cancer Center, University of North Carolina
Received: 1 May 2017
Accepted: 28 July 2017
First Online: 9 August 2017
Ethics approval and consent to participate
: This study was performed in compliance with the policies related to the use of human subjects of the Biomedical Institutional Review Board, study number 12–2314, and in compliance with the provisions of the Health Insurance Portability and Accountability Act (HIPAA). The committee members that approved the study, and their affiliations are: J. Herbert Patterson (Pharmacy), Beth Boyea (Reproductive Genetics), Ruth Ann Bark (Clinical Research Management), John Buse (Diabetes), David Edwards (Prisoner Representative), Stuart H. Gold (Oncology), Howard Kehrl (General Medicine), Paris Laliberte (Latino Health), Marjorie Land (unspecified), Steven Lichtman (Pediatrics), Robert Matthews (Anesthesiology, Nursing).All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
: All individuals who have data (images) presented have consented to have their data submitted for publication.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.